用于口服胰岛素输送的特定位置的自适应纳米纤维
Bozhang Xia1,2,3, Fengfei Xu1,2, Junge Chen4
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, No. 11, First North Road, Zhongguancun, Beijing, 100190, P. R. China.
Science advances
|September 24, 2025
概括
乳制品纳米微粒 (MiNVs) 为口服胰岛素提供了一种新的方法. 这些适应性纳米纤维克服了生物障碍,在糖尿病模型中显著改善了胰岛素的生物可用性和血糖控制.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 口服胰岛素因胃肠道环境,肠道透性和肝脏清除而面临挑战.
- 改善患者的服从是胰岛素治疗的一个关键目标.
研究的目的:
- 开发特定的适应性乳制品纳米纤维 (MiNVs),用于有效的口服胰岛素输送.
- 克服肠道和肝脏障碍,提高胰岛素的生物可用性.
主要方法:
- MiNVs被设计为结合IgG,促进FcRn介导的细胞转移,避免溶酶体降解.
- MiNVs的设计是为了在响应肝脏生物醇时释放胰岛素.
- 在1型糖尿病老鼠和迷你猪模型中评估了有效性.
主要成果:
- 通过MiNVs输送的口服胰岛素的生物可用性在糖尿病大鼠中达到20.4%,比自由胰岛素增加了20倍.
- 在老鼠和小猪模型中,MiNVs证明了有效的长期血糖控制.
- 面向特定地点的MiNVs的适应性使得有效的横体运输和有针对性的释放成为可能.
结论:
- 特定于位点的适应性MiNV显示出对口服胰岛素的注射有显著的前景.
- 开发的纳米纤维有效地克服了生物障碍,并改善了血糖控制.
- 这种方法提高了胰岛素的生物可用性,并为注射提供了潜在的替代方案.
相关概念视频
Insulin Formulations: Types and Delivery
658
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
658
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K


